GlaxoSmithKline Pharma to consider Q3 and 9M results
On 11 February 2016
GlaxoSmithKline Pharma will hold a board meeting on 11 February 2017 for approval and declaration of Un-Audited Financial Results for the third quarter and nine months ended 31 December 2016.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content